Discover 3,494 paid clinical trials in Torrance, California. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 3,494
A Study to Learn About How 20-Valent Pneumococcal Conjugate Vaccine Works in a Real-world Setting
for
Pneumonia
Location: Los Angeles CA, Pasadena CA, Ontario CA, Riverside CA,
Sponsor: Pfizer
Sex: All
Age: 65+
Code: NCT05452941
Recruiting
Beamion BCGC-1: A Study to Find a Suitable Dose of Zongertinib Used Alone and in Combination With Other Treatments to Test Whether it Helps People With Different Types of HER2+ Cancer That Has Spread
for
Metastatic Breast Cancer, Metastatic Gastric Adenocarcinoma,
Location: Cerritos CA, Los Angeles CA, Orange CA, San Diego CA,
Sponsor: Boehringer Ingelheim
Sex: All
Age: 18+
Code: NCT06324357
Phase 1, Phase 2, Recruiting
A Study Comparing the Efficacy and Safety of Zanidatamab to Trastuzumab, Each in Combination With Physician's Choice Chemotherapy, for the Treatment of Participants With Metastatic HER2-positive Breast Cancer
for
Metastatic HER2-positive Breast Cancer
Location: Cerritos CA, Los Angeles CA, Glendale CA,
Sponsor: Jazz Pharmaceuticals
Sex: All
Age: 18+
Code: NCT06435429
Phase 3, Recruiting
A Study of Pirtobrutinib (LOXO-305) Versus Ibrutinib in Participants With Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL)
Location: Los Angeles CA, West Valley City UT, Seattle WA,
Sponsor: Verastem, Inc.
Sex: All
Age: 18+
Code: NCT07644559
Phase 2, Recruiting
A Study of Mutant Selective-Inhibitor (CGT6297), in Patients With Advanced Solid Tumors
for
PIK3CA Mutations, Advanced Solid Tumors, Adult,
Location: Los Angeles CA, Scottsdale AZ, West Valley City UT,
Sponsor: Cogent Biosciences, Inc.
Sex: All
Age: 18+
Code: NCT07383506
Phase 1, Recruiting
A Study of APG-3288 in Relapsed/Refractory Blood Cancers
for
Relapsed/Refractory Hematological Malignancies,
Location: Los Angeles CA, Grand Rapids MI, East Brunswick NJ
Sponsor: Ascentage Pharma Group Inc.
Sex: All
Age: 18+
Code: NCT07424833
Phase 1, Recruiting
A Phase I/II Study of CS2009 in Participants With Advanced Solid Tumors
for
Advanced Solid Tumors
Location: Los Angeles CA, Irving TX
Sponsor: CStone Pharmaceuticals
Sex: All
Age: 18+
Code: NCT06741644
Phase 1, Phase 2, Recruiting
Study of RGT-490 in Patients With PIK3CA-Mutated Advanced Solid Tumors
for
Breast Cancer, Ovarian Cancer, Endometrial Cancer,
Location: Los Angeles CA, San Antonio TX, Houston TX, Fairfax VA
Sponsor: Regor Pharmaceuticals Inc.
Sex: All
Age: 18+
Code: NCT07524322
Phase 1, Recruiting
A Study of ASP546C in Adults With Gastroesophageal Cancer, Pancreatic Cancer or Other Solid Tumors
for
Gastric or Gastro-esophageal Junction (GEJ) Adenocarcinoma,
Location: Los Angeles CA, West Valley City UT, San Antonio TX,
Sponsor: Astellas Pharma Global Development, Inc.
Sex: All
Age: 18+
Code: NCT07488676
Phase 1, Phase 2, Recruiting
Symbiotic-GI-13: A Study to Learn About Study Medicine Called PF-08634404 as a Single Treatment and Combination Treatment in Adult Participants With a Liver Cancer Called Hepatocellular Carcinoma, That is Too Advanced to be Removed by Surgery and May Have Spread to Other Parts of the Body.
for
Carcinoma, Hepatocellular, Hepatocellular Cancer,
Location: Los Angeles CA, Pasadena CA, Orange CA, Irvine CA,
Sponsor: Pfizer
Sex: All
Age: 18+
Code: NCT07227012
Phase 1, Phase 2, Recruiting
A Study of MUC16-Directed Antibody Drug Conjugate HWK-016 in Participants With Advanced Solid Tumors.
for
PROC, Platinum Resistant Ovarian Cancer, Endometrial Cancer
Location: Los Angeles CA, Salt Lake City UT, Dallas TX,
Sponsor: Whitehawk Therapeutics, Inc.
Sex: All
Age: 18+
Code: NCT07470853
Phase 1, Recruiting
Symbiotic-Lung-20: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Different Anticancer Agents in Advanced Cancers
for
Advanced/Metastatic Non-Small Cell Lung Cancer,
Location: Los Angeles CA, Fullerton CA, Panorama City CA,
Sponsor: Pfizer
Sex: All
Age: 18+
Code: NCT07227298
Phase 1, Phase 2, Recruiting
Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid Tumors
Location: Los Angeles CA, Duarte CA, San Diego CA, Portland OR,
Sponsor: SystImmune Inc.
Sex: All
Age: 18+
Code: NCT06293898
Phase 1, Recruiting
A Study to Evaluate the Safety, Pharmacokinetics, and Anti-Tumor Activity of VVD-133214 as Monotherapy and in Combination in Participants With Advanced Solid Tumors